How are you clinically incorporating the data presented from RT Charm at ASTRO 2024?
Are you offering patients hypofractionated PMRT in your practice following ASTRO 2024 plenary session presentation of RT CHARM?
Join Mednetto vote and see how they answered.
This is an appropriate question with the presentation of RT CHARM at ASTRO a few weeks ago. We have been utilizing hypofractionated NON-reconstruction PMRT and regional nodal breast RT for years in my practice given our large geographic catchment area. As a general rule, I feel it's always best prac...
Join for free or sign in to see the full answer
Yes, routinely offering hypofractionation with RT CHARM and FABREC supporting it.
Join for free or sign in to see the full answer
It’s becoming increasingly difficult to rationalize conventionally-fractionated radiotherapy for breast cancer.
Join for free or sign in to see the full answer
Additional information on the safety of hypofractionated nodal radiotherapy recently emerged. The 2024 ESMO presentation 2310 of HypoG-01 solidifies the use of nodal hypofractionation as a safe method to treat the breast or chest wall and nodal basins. A broad range of stages, pT1-3 & pN0-3, HER2, r...
Join for free or sign in to see the full answer
RT CHARM is written and being submitted for publication.
Join for free or sign in to see the full answer